sharetrader
Page 4 of 10 FirstFirst 12345678 ... LastLast
Results 31 to 40 of 99
  1. #31
    Senior Member
    Join Date
    Aug 2008
    Posts
    588

    Default

    Quote Originally Posted by dagoldtoof View Post
    Long time holder, appears the implanting of cells in Parkinson patients look promising ..In a bottom drawer....
    For sure, get all the Parkinsons patients implanted and stable and thats a huge stepping stone. It'l satisfy contractual requirments and bring another injection of cash.
    Its a pretty exciting time for LCT, and yes agreed, it is bottom drawer stuff but the potential is second to none in my opinion.

  2. #32
    Member
    Join Date
    Jul 2011
    Posts
    48

    Default

    Has anyone go info on the potential market for NTCell?
    Patients in US = 500,000 to 1,500,000 with 50,000 to 60,000 new cases reported annually.

    80,000 in Aus. 9,000 annually.

    Any idea of treatment costs and COGS? Has this been discussed?

    Thanks.

  3. #33
    Member
    Join Date
    Apr 2010
    Posts
    45

    Default

    Happy to still hold these shares.......Takes a long time for trials etc, but starting to show results in halting Parkinsons sufferers...

  4. #34
    IMO
    Join Date
    Aug 2010
    Location
    Floating Anchor Shoals
    Posts
    9,736

    Default

    Any trial news imminent dagoldtoof?. I see Milford asset management have bought re 23 million shares!!.

  5. #35
    Member
    Join Date
    Apr 2010
    Posts
    45

    Default

    I get my info from Hot Cooper, like the fact Milford have doubled their holding...

  6. #36
    IMO
    Join Date
    Aug 2010
    Location
    Floating Anchor Shoals
    Posts
    9,736

    Default

    Well that stopped the thread in its tracks

  7. #37
    Member
    Join Date
    Jul 2013
    Posts
    114

    Default

    LCT is in a very exciting place the Phase 11b NTCELL should be well over by now 18 more patients implanted with NTCELL bringing the total to 22 patients. We have to wait 26 weeks for the results of Phase 11 the trial aims to confirm the most effective dose of NTCELL.

    The June 2016 BIO International Convention is the largest pharmaceutical and bio conference in the world. LCT has been invited to present. 19-23 June the International Congress of Parkinson's Disease and Movement Disorders which will take place in Berlin. Dr Barry Snow will present an update on the safety and efficacy of NTCELL.

    If the trial is a success it will mean a fast track approval for paying patients.

  8. #38
    Member Kees's Avatar
    Join Date
    Aug 2007
    Location
    christchurch
    Posts
    207

    Default

    LCT made a good run this week expect it to keep going to.

  9. #39
    Member
    Join Date
    Jun 2011
    Posts
    266

    Default

    2 banger ! Chucked a few bucks in a month ago !

  10. #40
    Member Kees's Avatar
    Join Date
    Aug 2007
    Location
    christchurch
    Posts
    207

    Default

    Quote Originally Posted by cammo View Post
    2 banger ! Chucked a few bucks in a month ago !
    Good one , going to hang in there this time think it will run a lot further remember these at 40c

Bookmarks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •